COVID-19 Update IgNS thanks all healthcare professionals and service providers, first responders, government agencies, and the healthcare industry who are working tirelessly in the face of the COVID-19 pandemic.  Roche receives emergency approval for COVID-19...

On Sept. 23, the Healthcare Quality and Safety team at USP issued a letter announcing that it would delay the planned Dec. 1 implementation of three of its chapters: the revised <795> Pharmaceutical Compounding—Nonsterile Preparations and <797>...

Examining the Application of Immunoglobulin in Multiple Disease States: A Review of Evidence Activity Overview: The administration of immunoglobulin (Ig) has become common practice in the treatment of patients with immunodeficiencies, and, more recently, in other...

Immunoglobulin National Society (IgNS) is pleased to announce a two-year corporate sponsorship agreement with Managed Health Care Associates, Inc., a health care services and software company based in Florham Park, NJ. This sponsorship agreement is part of both...

Dr. Ness brings a wealth of clinical expertise in Ig therapy, as well as a strong leadership background in her professional career. She has worked in both national specialty …

In the past five years, IgNS has brought forth a major shift in the practice of Ig therapy, establishing a formal educational platform, professional certification, and the standards …

The goals of the IgNS certification, and the Immunoglobulin Certified Nurse (IgCN^®) Credential are to protect the public by assessment, validation and documentation …

The Immunoglobulin Nursing Society (IgNS) announced the development of the first certification program for immunoglobulin nurses. The ultimate goal of the IgNS certification program is the protection of patients receiving immunoglobulin therapy...